Projects per year
Personal profile
Education
- 2002-2007 Postdoctoral training in Hematology and Oncology, Mount Sinai School of Medicine, New York, USA
- 1997.09-2002.05 Ph.D., in Biology, City University of New York, USA
- 1994.09-1997.07 M.S., in Biology, City University of New York , USA
- 1984.09-1988.06 B.S., Department of Plant Pathology, National Chung Hsing University
Experience
- 2024.08- Professor, Graduate Institute of Medical Sciences, Taipei Medical University
- 2018.02- Associate Professor, International Master/Ph.D. Program in Medicine, College of Medicine, Taipei Medical University
- 2018.02- Associate Professor, International Ph.D. Program for Cell Therapy and Regeneration Medicine, Taipei Medical University
- 2016.11-2017.10 Associate Professor, International Master/Ph.D. Program in Medicine, College of Medicine, Taipei Medical University
- 2013.02-2024.07 Associate Professor, Graduate Institute of Medical Sciences, Taipei Medical University
- 2009.08-2013.07 Assistant Professor, Graduate Institute of Medical Sciences, Taipei Medical University
- 2009.02-2009.07 Assistant Professor, Institute of Microbiology & Immunology, Chung Shan Medical University
- 2007.10-2008.10 Research Associate, Hematology and Oncology/Medicine, Mount Sinai School of Medicine, New York, USA
- 1994-2008 Postdoctoral Fellow, Hematology and Oncology/Medicine, Mount Sinai School of Medicine, New York, USA
- 1994-2001 Adjunct Lecturer, Biology, Queens College, City University of New York
Awards
- 2007 Travel Award, ASH 50th Annual Meeting, San Diego, CA
Research Interests
- Leukocyte trafficking, Cancer biology, Wound healing, Traumatic brain injury
Fingerprint
Dive into the research topics where Jungshan Chang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 16 Finished
-
The Oncogenic Role and Targeted Therapeutic Potential of Alpha 9 Nicotinic Acetylcholine Receptors on Breast Cancers: Emphasizing in Pre-Clinical Assessment of Biphasic Antibody Nano-Drugs in Xenografts( III )
Chang, J. (PI)
8/1/19 → 7/31/20
Project: A - Government Institution › b - National Science and Technology Council
-
The Oncogenic Role and Targeted Therapeutic Potential of Alpha 9 Nicotinic Acetylcholine Receptors on Breast Cancers: Emphasizing in Pre-Clinical Assessment of Biphasic Antibody Nano-Drugs in Xenografts(II)(2/3)
Chang, J. (PI)
8/1/18 → 8/1/19
Project: A - Government Institution › b - National Science and Technology Council
-
The Oncogenic Role and Targeted Therapeutic Potential of Alpha 9 Nicotinic Acetylcholine Receptors on Breast Cancers: Emphasizing in Pre-Clinical Assessment of Biphasic Antibody Nano-Drugs in Xenografts( I )
Chang, J. (PI)
8/1/17 → 7/31/18
Project: A - Government Institution › b - National Science and Technology Council
-
Characterizing the Therapeutic Roles of Depleting Brain-Infiltrated Leukocytes Using Pan-Selectin Antagonist and Intravenous Immunoglobulins in Traumatic Brain Injury
Chang, J. (PI)
8/1/15 → 7/31/16
Project: A - Government Institution › b - National Science and Technology Council
-
以MALDI與TOF-SIMS研究大腸癌病人血液與組織內CTGF與PTEN表現探討
Chang, J. (PI)
6/1/14 → 5/31/16
Project: C - Project of Alliance › t - Taipei Municipal Wanfang Hospital
-
Apoptotic Effect of Simpor Leaf Extract (Dillenia suffruticosa) from Belitung on Colorectal Cancer Cells WiDr
Rahayu, S., Rinendyaputri, R., Nikmah, U. A., Supriyatin, Irnidayanti, Y., Priambodo, R., Nazlihatunnisa, Rusmalina, D. L., Syahira, R. H. & Chang, J., Dec 2024, In: Trends in Sciences. 21, 12, 8316.Research output: Contribution to journal › Article › peer-review
Open Access -
Characterization of chicken-derived antibody against Alpha-Enolase of Streptococcus pneumoniae
Lee, C. H., Wu, C. J., Yang, Y. Y., Wang, W. C., Leu, S. J., Wu, C. T., Kao, P. S., Liu, K. J., Tsai, B. Y., Chiang, Y. W., Mao, Y. C., Benedict Dlamini, N. & Chang, J., Feb 15 2024, In: International Immunopharmacology. 128, 111476.Research output: Contribution to journal › Article › peer-review
5 Citations (Scopus) -
Engineering H2O2 Self-Supplying Platform for Xdynamic Therapies via Ru-Cu Peroxide Nanocarrier: Tumor Microenvironment-Mediated Synergistic Therapy
Dirersa, W. B., Kan, T. C., Chang, J., Getachew, G., Ochirbat, S., Kizhepat, S., Wibrianto, A., Rasal, A., Chen, H. A., Ghule, A. V., Chou, T. H. & Chang, J. Y., May 15 2024, In: ACS Applied Materials and Interfaces. 16, 19, p. 24172-24190 19 p.Research output: Contribution to journal › Article › peer-review
Open Access8 Citations (Scopus) -
Investigation of the α9-nicotinic receptor single nucleotide polymorphisms induced oncogenic properties and molecular mechanisms in breast cancer
Liao, Y. C., Wang, L. H., Hung, M. C., Cheng, T. C., Lin, Y. C., Chang, J., Tu, S. H., Wu, C. H., Yen, Y., Hsieh, Y. C., Chen, L. C. & Ho, Y. S., Nov 8 2024, In: Human Molecular Genetics. 33, 22, p. 1948-1965 18 p.Research output: Contribution to journal › Article › peer-review
-
Nucleos(t)ide analogues potentially activate T lymphocytes through inducing interferon expression in hepatic cells and patients with chronic hepatitis B
Ho, A. S., Chang, J., Lee, S. D., Sie, Z. L., Shih, H. F., Yeh, C., Peng, C. L., Dev, K. & Cheng, C. C., Dec 2024, In: Scientific Reports. 14, 1, 25286.Research output: Contribution to journal › Article › peer-review
Open Access
Datasets
-
CCDC 1517710: Experimental Crystal Structure Determination
Lu, N. (Creator), Alagesan, M. (Creator), Ho, C.-L. (Creator), Wei, R.-J. (Creator), Kung, C.-C. (Creator), Chang, J.-S. (Creator), Wen, Y.-S. (Creator) & Liu, L.-K. (Creator), Cambridge Crystallographic Data Centre, 2016
DOI: 10.5517/ccdc.csd.cc1my9d8, http://www.ccdc.cam.ac.uk/services/structure_request%3Fid=doi:10.5517/ccdc.csd.cc1my9d8&sid=DataCite
Dataset
-
MOESM2 of STAT3 induces G9a to exacerbate HER3 expression for the survival of epidermal growth factor receptor-tyrosine kinase inhibitors in lung cancers
Sie, Z.-L. (Creator), Chiang, Y.-W. (Creator), Chang, Y.-F. (Creator), Ho, A.-S. (Contributor), Cheng, C.-C. (Contributor), Chang, J. (Creator) & Lim, K.-H. (Contributor), Figshare, 2019
DOI: 10.6084/m9.figshare.9993560.v1, https://doi.org/10.6084%2Fm9.figshare.9993560.v1
Dataset
-
MOESM5 of STAT3 induces G9a to exacerbate HER3 expression for the survival of epidermal growth factor receptor-tyrosine kinase inhibitors in lung cancers
Ho, A.-S. (Contributor), Chiang, Y.-W. (Creator), Chang, Y.-F. (Creator), Chang, J. (Creator), Lim, K.-H. (Contributor), Sie, Z.-L. (Creator) & Cheng, C.-C. (Contributor), Figshare, 2019
DOI: 10.6084/m9.figshare.9993575.v1, https://doi.org/10.6084%2Fm9.figshare.9993575.v1
Dataset
-
MOESM10 of STAT3 induces G9a to exacerbate HER3 expression for the survival of epidermal growth factor receptor-tyrosine kinase inhibitors in lung cancers
Chiang, Y.-W. (Creator), Lim, K.-H. (Contributor), Sie, Z.-L. (Creator), Chang, Y.-F. (Creator), Chang, J. (Creator), Ho, A.-S. (Contributor) & Cheng, C.-C. (Contributor), Figshare, 2019
DOI: 10.6084/m9.figshare.9993536.v1, https://doi.org/10.6084%2Fm9.figshare.9993536.v1
Dataset
-
MOESM4 of STAT3 induces G9a to exacerbate HER3 expression for the survival of epidermal growth factor receptor-tyrosine kinase inhibitors in lung cancers
Cheng, C.-C. (Contributor), Sie, Z.-L. (Creator), Lim, K.-H. (Contributor), Chang, J. (Creator), Chiang, Y.-W. (Creator), Chang, Y.-F. (Creator) & Ho, A.-S. (Contributor), Figshare, 2019
DOI: 10.6084/m9.figshare.9993569.v1, https://doi.org/10.6084%2Fm9.figshare.9993569.v1
Dataset